STUDI MEKANISME INTERAKSI GLIKLAZID-SIPROFLOKSASIN PADA TRANSPORTER P- GLYCOPROTEIN DENGAN PEMBERIAN KINIDIN PADA TIKUS WISTAR JANTAN
Patients with type II Diabetes Mellitus along with complications such as urinary tract infection are usually treated by a combination of gliclazide and ciprofloxacin as therapy. Previous study showed that the interaction between gliclazide and ciprofloxacin caused ð?íðð?ð???» ®ð???»??? ®ð??? eli...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/45197 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Patients with type II Diabetes Mellitus along with complications such as urinary tract infection are
usually treated by a combination of gliclazide and ciprofloxacin as therapy. Previous study showed
that the interaction between gliclazide and ciprofloxacin caused ð?íðð?ð???» ®ð???»??? ®ð???
elimination. It was assumed that the interaction involving P-glycoprotein (P-gp). This current
research was aimed to study the role of P-gp in the interaction between gliclazide and ciprofloxacin
using quinidine as a widely accepted P-gp inhibitor. Male wistar rats were divided into four groups
(n=5). Group I and II were given gliclazide and ciprofloxacin, respectively, while group III and IV were
given gliclazide and ciprofloxacin, respectively along with intravenous infusion of quinidine. Blood
samples were collected via femoral artery at pre-determined sampling points. Samples were
analyzed by HPLC and the pharmacokinetic parameters were defined. Plasma concentrations of
quinidine were determined to evaluate with the target concentration. Pharmacokinetic parameters
of gliclazide in group III showed a significant difference only in the tmax (1.50 ± 0.00 to 0.55 ± 0.11 h)
compared to group I. While pharmacokinetic parameters of ciprofloxacin in group IV differed from
ã????==??í??ð?ã ?ðã?ð»ð® ??¸±®?± ?± ????????ð???0.24 ± 0.03 to 0.07 ± 0.01 /h), clearance (16.67
± 3.89 to 9.44 ± 1.51 l/kg.h), tmax (0.75 ± 0.00 to 0.50 ± 0.00), also a significant increase (p<0.05) in
biological half life (2.97 ± 0.45 to 9.98 ± 1.34 h). Administration of gliclazide along with quinidine
did not cause any difference in its elimination parameters. While administration of ciprofloxacin
along with quinidine caused a significant decrease in elimination of ciprofloxacin indicated that
ciprofloxacin was a substrate of P-gp.
|
---|